First description of agonist and antagonist IP-10 in urine of patients with active TB
Linda Petrone(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Fabiola Ciccosanti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Gian María Fimia(Sapienza University of Rome), Gilda Cuzzi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Morten Rühwald(FIND), Giovanni Delogu(Università Cattolica del Sacro Cuore), Vincent Bondet(Inserm), Valentina Vanini(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Ivana Palucci(Institute of Microbiology), Thomas Blauenfeldt(Statens Serum Institut), Fabrizio Palmieri(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Darragh Duffy(Inserm)
Cited by 19
Related Papers
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Molecular definitions of autophagy and related processes
|The EMBO Journal|2017|1.6k
Autophagy in major human diseases
|The EMBO Journal|2021|1.6k